Alimera Sciences reported $-2747000 in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Alimera Sciences ALIM:US USD -2747000 1.44M
Bayer BAYN:GR EUR 2.45B 2.31B
Insmed INSM:US USD -119864000 21.78M
Novartis NOVN:VX USD 4.69B 34M
Regeneron Pharmaceuticals REGN:US USD 1.33B 49.4M
Roche Holding ROG:VX 13.44B 2.56B